Shaum Kabadi

Shaum Kabadi is a highly experienced Director with a background spanning 13 years in the pharmaceutical industry. Throughout his career, he has demonstrated strong strategic thinking skills and a knack for creative problem-solving. His approach is deeply rooted in customer insights, driving his commitment to delivering impactful solutions.

Shaum Kabadi boasts a rich portfolio of experience, including successful product launches in the United States and a significant focus on real-world evidence, which encompassed US label updates and registries. He thrives in collaborative environments, excelling in communication and coordination within matrix organizations. His past collaborations have involved departments such as Market Access, Medical, Digital, and Marketing.

Education-wise, Shaum has a strong academic background, holding a Ph.D. in Epidemiology and Biostatistics with an impressive GPA of 3.83 from Drexel University. Prior to this, he earned his M.P.H. in Epidemiology and Health Policy from the University of Medicine and Dentistry of New Jersey, achieving a GPA of 3.73. He initiated his academic journey with a B.A. in a Self-Designed Major in Biochemistry at The College of New Jersey after graduating from Marlboro High School.

Shaum Kabadi's professional journey includes serving as the Global Director of Real World Investigator at Sanofi. He has held key positions at renowned pharmaceutical companies such as AstraZeneca, where he served as the Director of Epidemiology and Real-World Evidence in Oncology, Health Economics and Outcomes Research Director in Hematology/Oncology, and the same role in Lupus, Kidney Disease, and Gout. Prior to AstraZeneca, he gained valuable experience at Pfizer as a Senior Manager in Predictive Informatics, at Amgen as a Manager/Senior Consultant at the Center for Observational Research, and at Merck as a US Outcomes Research Scientist.